Clinical Study
Conjunctivitis and Total IgE in Lacrimal Fluid: Lacrytest Screening
Table 1
Demographic characteristics
and groups of study.
| Patient | Group | Sex | Age | SPT | Patient | Group | Sex | Age | SPT |
| 1 | 1 | F | 14 | + | 31 | 2 | M | 8 | − | 2 | 1 | M | 37 | + | 32 | 2 | M | 5 | − | 3 | 1 | F | 52 | + | 33 | 2 | M | 65 | − | 4 | 1 | F | 12 | + | 34 | 2 | M | 9 | − | 5 | 1 | F | 39 | + | 35 | 2 | F | 25 | − | 6 | 1 | F | 28 | + | 36 | 2 | F | 76 | − | 7 | 1 | F | 49 | + | 37 | 2 | F | 74 | − | 8 | 1 | M | 30 | + | 38 | 2 | F | 74 | − | 9 | 1 | F | 24 | + | 39 | 2 | F | 14 | − | 10 | 1 | M | 21 | + | 40 | 2 | M | 34 | − | 11 | 1 | F | 25 | + | 41 | 2 | F | 52 | − | 12 | 1 | F | 14 | + | 42 | 2 | F | 43 | − | 13 | 1 | F | 15 | + | 43 | 2 | F | 36 | − | 14 | 1 | F | 43 | + | 44 | 2 | M | 25 | − | 15 | 1 | M | 33 | + | 45 | 2 | F | 17 | − | 16 | 1 | M | 24 | + | 46 | 3 | F | 8 | − | 17 | 1 | F | 39 | + | 47 | 3 | M | 9 | − | 18 | 1 | M | 33 | + | 48 | 3 | M | 10 | + | 19 | 1 | M | 36 | + | 49 | 3 | F | 7 | + | 20 | 1 | M | 28 | + | 50 | 3 | F | 6 | + | 21 | 1 | M | 27 | + | 51 | 3 | F | 8 | − | 22 | 1 | F | 33 | + | 52 | 3 | M | 9 | − | 23 | 1 | F | 18 | + | 53 | 3 | F | 9 | − | 24 | 1 | F | 70 | + | 54 | 3 | M | 8 | − | 25 | 1 | M | 55 | + | | | | | | 26 | 1 | M | 13 | + | | | | | | 27 | 1 | F | 59 | + | | | | | | 28 | 1 | M | 56 | + | | | | | | 29 | 1 | M | 39 | + | | | | | |
| 30 | 1 | M | 56 | + | | | | | |
|
|
1- IgE-mediated conjunctivitis
group. 2- Control group. 3- VKC. M: male. F: female. +: Positive SPT. −:
Negative SPT.
|